RE:RE:RE:Not encouraging Thanks, watchman. I dont expect it to happen either. .Plus, if as you say, everyone gets 6 months advance notice, that for all practical purposes elimintates risk of EUA ending for rapid tests. Would surely think we'll get this submitted within 6 months, like say, if advance notice was given tomorrow.
What I was thinking about though is maybe a little different than the situation you mentioned. Maybe I worded my concern incorrectly? Dont mean to split hairs, but look what happened to SONA.
Sona Nanotech Receives 'Deprioritization' from FDA; Health Canada Evaluation Continues | 2020-10-29 | Press Releases | Stockhouse Looks to me that in above case FDA simply made the decision to "deprioritize" that Co's EUA application for their rapid test. No 6 month advance warning. FDA says they didnt refuse EUA due to test performance. Looks to me that FDA just deprioritized their submission for EUA out of the blue. It was my understanding Sona could still apply for regular (non EUA) approval. I realize extremely low probablity this would ever happen to Acuvid, but we cant say its never happened in past. (When I do DD on a spec stock I analyze all the pro's and con's. For me the pro's still far outweigh the cons for THRM. But still, I dont totally disregard a con even if very low probablitity.)
Lets get this submission and approval completed already.